Cure Today

Imlunestrant-Based Therapy May Improve Survival Without Progression in Advanced Breast Cancer

Imlunestrant improved PFS in ESR1-mutated breast cancer compared to standard endocrine therapy, but not significantly in the overall population. Combining imlunestrant with Verzenio enhanced PFS in ...
ascopubs.org

Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer.
EurekAlert!

Next-generation SERD camizestrant significantly improves progression-free survival vs. fulvestrant in advanced ER+ HER2- breast cancer

image: Mafalda Oliveira, Senior Consultant at the Vall d’Hebron University Hospital’s Medical Oncology Department and Clinical Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Breast ...
Fred Hutch

A triplet of drugs extends progression-free survival in advanced breast cancer

Breast cancer treatment has been a showcase of increasing precision—from surgery and chemotherapy, to endocrine therapies and targeted treatments. Breast cancer subtypes can be defined by expression ...
Morningstar

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain ...

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or ...